We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

163 hedge funds and large institutions have $974M invested in GenMark Diagnostics, Inc in 2020 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 52 increasing their positions, 56 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 20

10% more funds holding

Funds holding: 148 → 163 (+15)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

3% less capital invested

Capital invested by funds: $1,000M → $974M (-$25.6M)

7% less repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 56

73% less call options, than puts

Call options by funds: $1.63M | Put options by funds: $6.01M

Holders
163
Holders Change
+15
Holders Change %
+10.14%
% of All Funds
3.29%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
35
Increased
52
Reduced
56
Closed
20
Calls
$1.63M
Puts
$6.01M
Net Calls
-$4.38M
Net Calls Change
-$5.96M

Top Buyers

Rank Fund Capital Flow
1
Macquarie Group
Macquarie Group
Australia
+$20.9M
2
Invesco
Invesco
Georgia
+$12.1M
3
AC
Armistice Capital
New York
+$12.1M
4
DCM
Driehaus Capital Management
Illinois
+$10.7M
5
Morgan Stanley
Morgan Stanley
New York
+$10M

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$24.4M
2
Millennium Management
Millennium Management
New York
-$18.5M
3
PCM
Portolan Capital Management
Massachusetts
-$11.8M
4
Deutsche Bank
Deutsche Bank
Germany
-$11M
5
O
OrbiMed
New York
-$10.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
PC
126
Polar Capital
United Kingdom
$158K +$170K +11,100 New
QSS
127
Quantitative Systematic Strategies
Florida
$158K +$170K +11,120 New
AB
128
Amalgamated Bank
New York
$154K -$627 -41 -0.4%
QT
129
Quantbot Technologies
New York
$152K -$34.6K -2,267 -17%
DCM
130
Donaldson Capital Management
Indiana
$142K +$153K +10,000 New
TWA
131
TCI Wealth Advisors
Arizona
$97K – – –
SGAM
132
Smith Group Asset Management
Texas
$97K +$104K +6,830 New
Zurich Cantonal Bank
133
Zurich Cantonal Bank
Switzerland
$87K – – –
AIP
134
Ameritas Investment Partners
Nebraska
$85K – – –
Citigroup
135
Citigroup
New York
$84K -$267K -17,462 -75%
Nisa Investment Advisors
136
Nisa Investment Advisors
Missouri
$77K +$34.4K +2,250 +70%
Osaic Holdings
137
Osaic Holdings
Arizona
$72K -$7.98K -522 -9%
Canada Life
138
Canada Life
Manitoba, Canada
$55K – – –
MAM
139
Meeder Asset Management
Ohio
$34K -$18.8K -1,227 -34%
AS
140
Altshuler Shaham
Israel
$32K +$34.2K +2,235 New
Acadian Asset Management
141
Acadian Asset Management
Massachusetts
$31K +$33K +2,161 New
HIA
142
Harbor Investment Advisory
Maryland
$25K +$20.7K +1,356 +362%
FCH
143
Freestone Capital Holdings
Washington
$14.2K +$15.3K +1,000 New
First Manhattan
144
First Manhattan
New York
$14K – – –
LWM
145
Liberty Wealth Management
California
$14K – – –
ASN
146
Advisory Services Network
Georgia
$14K +$15.4K +1,007 New
Millennium Management
147
Millennium Management
New York
$13.1K -$18.5M -1,210,037 -57%
PHK
148
Point72 Hong Kong
Hong Kong
$11K -$55.3K -3,617 -82%
US Bancorp
149
US Bancorp
Minnesota
$9K +$3.06K +200 +48%
CG
150
Cutler Group
California
$7K -$63.6K -4,160 -89%
4 5
6
7 8

GNMK Hedge Fund Activity: Q3 2020 in Review

163 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q3 2020, worth a combined $974M — down 2.6% from $1,000M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new GNMK positions and 20 closed out — a net gain of 15 holders — while 52 added to existing stakes and 56 trimmed.

The largest buyer was Macquarie Group, adding an estimated $20.9M. The largest seller was Consonance Capital Management, cutting an estimated $24.4M.

  • 163 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q3 2020, up from 148 in Q2 2020.
  • Funds reported $974M of GenMark Diagnostics, Inc stock for Q3 2020, down 2.6% quarter-over-quarter.
  • 35 funds opened new GenMark Diagnostics, Inc positions in Q3 2020 and 20 closed out, a net change of +15 holders.
  • The largest GenMark Diagnostics, Inc buyer in Q3 2020 was Macquarie Group, an estimated $20.9M added.
  • The largest GenMark Diagnostics, Inc seller in Q3 2020 was Consonance Capital Management, an estimated $24.4M sold.

Based on aggregated 13F filings for Q3 2020.